tiprankstipranks
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
US Market

ZyVersa Therapeutics (ZVSA) Technical Analysis

111 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
ZyVersa Therapeutics’s (ZVSA) Moving Averages Convergence Divergence (MACD) indicator is -0.40, suggesting ZyVersa Therapeutics is a Sell.
ZyVersa Therapeutics’s (ZVSA) 20-Day exponential moving average is 5.85, while ZyVersa Therapeutics’s (ZVSA) share price is $5.29, making it a Sell.
ZyVersa Therapeutics’s (ZVSA) 50-Day exponential moving average is 6.86, while ZyVersa Therapeutics’s (ZVSA) share price is $5.29, making it a Sell.

ZyVersa Therapeutics (ZVSA) Pivot Points

May 15, 2024, 05:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.91
5.05
5.25
5.39
5.59
5.73
5.93
Fibonacci
5.05
5.18
5.26
5.39
5.52
5.60
5.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ZyVersa Therapeutics (ZVSA) Moving Averages

May 15, 2024, 05:43 PM
Period
Simple
Exponential
MA5
5.40Sell
5.46Sell
MA10
5.63Sell
5.58Sell
MA20
5.69Sell
5.85Sell
MA50
6.93Sell
6.86Sell
MA100
7.18Sell
12.00Sell
MA200
23.49Sell
31.95Sell
ZyVersa Therapeutics’s (ZVSA) 10-Day exponential moving average is 5.58, while ZyVersa Therapeutics’s (ZVSA) share price is $5.29, making it a Sell.
ZyVersa Therapeutics’s (ZVSA) 100-Day exponential moving average is 12.00, while ZyVersa Therapeutics’s (ZVSA) share price is $5.29, making it a Sell.
ZyVersa Therapeutics’s (ZVSA) stock price is $5.29 and ZyVersa Therapeutics’s (ZVSA) 50-day simple moving average is 6.93, creating a Sell signal.
ZyVersa Therapeutics’s (ZVSA) stock price is $5.29 and ZyVersa Therapeutics’s (ZVSA) 100-day simple moving average is 7.18, creating a Sell signal.
ZyVersa Therapeutics’s (ZVSA) stock price is $5.29 and ZyVersa Therapeutics’s (ZVSA) 200-day simple moving average is 23.49, creating a Sell signal.

ZyVersa Therapeutics (ZVSA) Technical Indicators

May 15, 2024, 05:43 PM
Name
Value
Implied Action
RSI (14)
41.74
Neutral
STOCH (9,6)
17.35
Buy
STOCHRSI (14)
41.30
Neutral
MACD (12,26)
-0.40
Sell
ADX (14)
12.36
Buy
Williams %R
-62.39
Buy
CCI (14)
-90.01
Neutral
ATR (14)
0.74
-
Ultimate Oscillator
48.49
Neutral
ROC
-13.28
Sell
ZyVersa Therapeutics’s (ZVSA) Relative Strength Index (RSI) is 41.74, creating a Neutral signal.
ZyVersa Therapeutics’s (ZVSA) Trend Strength Indicator (ADX) is 12.36, creating a Buy signal.
ZyVersa Therapeutics’s (ZVSA) Commodity Channel Index (CCI) is -90.01, creating a Neutral signal.
ZyVersa Therapeutics’s (ZVSA) Price Rate of Change (ROC) is -13.28, creating a Sell signal.

FAQ

Is ZVSA a Buy, Hold, or Sell?
Based on ZVSA’s technical indicators, ZVSA is a Strong Sell.
    What is ZVSA’s RSI (14)?
    ZVSA’s RSI (14) is 41.74, which suggests ZVSA is a Neutral.
      What is ZVSA’s MACD?
      ZVSA’s MACD is -0.40, which suggests ZVSA is a Sell.
        What is ZVSA’s 5-day moving average?
        ZVSA’s 5-day moving average is 5.40, which suggests ZVSA is a Sell.
          What is ZVSA’s 20-day moving average?
          ZVSA 20-day moving average is 5.69, which suggests ZVSA is a Sell.
            What is ZVSA’s 50-day moving average?
            ZVSA’s 50-day moving average is 6.93, which suggests ZVSA is a Sell.
              What is ZVSA’s 200-day moving average?
              ZVSA’s 200-day moving average is 23.49, which suggests ZVSA is a Sell.
                What is ZVSA’s Williams % R (14)?
                ZVSA’s Williams % R (14) is -62.39, which suggests ZVSA is a Buy.
                  What is ZVSA’s CCI (14)?
                  ZVSA’s CCI (14) is -90.01, which suggests ZVSA is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis